Growth hormone–secreting macroadenoma of the pituitary gland successfully treated with the radiolabeled somatostatin analog 90Y-DOTATATE: case report

Akromegalia — nowe spojrzenie na pacjenta. Polskie propozycje postępowania diagnostyczno-terapeutycznego w akromegalii w świetle aktualnych doniesień

(2014) Marek Bolanowski et al.   Endokrynologia Polska

Expert consensus document: A consensus on the medical treatment of acromegaly

(2014) Andrea Giustina et al.   Nature Reviews Endocrinology

PET/CT assessment of neuroendocrine tumors of the lung with special emphasis on bronchial carcinoids

(2014) Filippo Lococo et al.   TUMOR BIOLOGY

The joint IAEA, EANM, and SNMMI practical guidance on peptide receptor radionuclide therapy (PRRNT) in neuroendocrine tumours

(2013) John J. Zaknun et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Treatment with the Radiolabelled Somatostatin Analog177Lu-DOTATATE for Advanced Pancreatic Neuroendocrine Tumors

(2013) Maddalena Sansovini et al.   NEUROENDOCRINOLOGY

Place of Preoperative Treatment of Acromegaly with Somatostatin Analog on Surgical Outcome: A Systematic Review and Meta-Analysis

(2013) Francisco Pita-Gutierrez et al.   PLoS One

The Liege Acromegaly Survey (LAS): A new software tool for the study of acromegaly

(2012) Patrick Petrossians et al.   ANNALES D ENDOCRINOLOGIE

Treatment of Gastroenteropancreatic Neuroendocrine Tumors with Peptide Receptor Radionuclide Therapy

(2012) Esther I. van Vliet et al.   NEUROENDOCRINOLOGY

A consensus on the diagnosis and treatment of acromegaly complications

(2012) S. Melmed et al.   Pituitary

Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly

(2012) Andrea Giustina et al.   PLoS One

The role of nuclear medicine in modern therapy of cancer

(2012) Gabriela Kramer-Marek et al.   TUMOR BIOLOGY

Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?

(2011) Jolanta Kunikowska et al.   EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Failure of temozolomide and conventional doses of pegvisomant to attain biochemical control in a severe case of acromegaly

(2010) Emilie Morin et al.   Pituitary

Pituitary tumor size in acromegaly during pegvisomant treatment: experience from MR re-evaluations of the German Pegvisomant Observational Study

(2009) M Buchfelder et al.   EUROPEAN JOURNAL OF ENDOCRINOLOGY